Home
Data
Calendar
Blog
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Value | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | NA | NA | NA | |
| Weighted Average Number Of Diluted Shares Outstanding | 26.80 | NA | 26.55 | 26.63 | 27.95 | NA | 28.29 | 28.20 | 27.71 | NA | 27.44 | 27.39 | 27.36 | NA | 27.32 | 27.28 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 20.38 | 20.27 | NA | NA | 2.64 | 3.50 | NA | |
| Weighted Average Number Of Shares Outstanding Basic | 26.80 | NA | 26.55 | 26.63 | 27.95 | NA | 28.29 | 28.20 | 27.71 | NA | 27.44 | 27.39 | 27.36 | NA | 27.32 | 27.28 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 20.38 | 20.27 | NA | NA | 2.64 | 2.63 | NA | |
| Earnings Per Share Basic | -1.64 | -1.59 | -1.41 | -1.50 | -1.58 | -0.93 | -1.18 | -1.15 | -1.31 | -1.19 | -0.24 | -0.02 | -0.66 | 1.23 | -0.87 | -0.79 | NA | -0.75 | -1.15 | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 | -0.63 | -0.30 | -0.45 | -0.13 | -0.75 | -1.73 | -0.42 | 0.07 | -0.34 | |
| Earnings Per Share Diluted | -1.64 | -1.59 | -1.41 | -1.50 | -1.58 | -0.93 | -1.18 | -1.15 | -1.31 | -1.19 | -0.24 | -0.02 | -0.66 | 1.23 | -0.87 | -0.79 | NA | -0.75 | -1.15 | -0.89 | -0.82 | -0.64 | -0.66 | -0.57 | -0.63 | -0.30 | -0.45 | -0.13 | -0.75 | -1.73 | -0.42 | 0.05 | -0.34 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue From Contract With Customer Excluding Assessed Tax | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 | |
| Revenue From Contract With Customer Including Assessed Tax | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 | |
| Revenues | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 | |
| Operating Expenses | 49.38 | 51.14 | 41.05 | 43.60 | 45.77 | 32.78 | 30.93 | 29.02 | 32.72 | 32.17 | 27.65 | 30.56 | 29.61 | 26.66 | 24.34 | 22.64 | 25.25 | 25.26 | 33.74 | 31.66 | 24.77 | 19.66 | 21.89 | 14.41 | 15.76 | 10.15 | 9.09 | 9.55 | 9.99 | 5.93 | 4.29 | 3.49 | 6.00 | |
| Research And Development Expense | 37.04 | NA | 30.88 | 32.92 | 34.96 | 23.37 | 22.06 | 20.84 | 22.52 | 26.78 | 22.22 | 25.31 | 24.18 | 21.57 | 19.54 | 17.95 | 20.97 | 21.43 | 29.93 | 27.35 | 20.63 | 15.92 | 17.88 | 10.58 | 11.81 | 7.61 | 6.70 | 7.21 | 7.93 | 5.02 | 3.28 | 2.33 | 4.79 | |
| General And Administrative Expense | 12.34 | 10.28 | 10.17 | 10.68 | 10.82 | 9.41 | 8.86 | 8.17 | 10.20 | 5.39 | 5.43 | 5.25 | 5.42 | 5.09 | 4.79 | 4.69 | 4.29 | 3.83 | 3.81 | 4.31 | 4.14 | 3.74 | 4.00 | 3.83 | 3.95 | 2.54 | 2.39 | 2.35 | 2.05 | 0.91 | 1.01 | 1.15 | 1.22 | |
| Operating Income Loss | -42.20 | -42.13 | -37.73 | -40.14 | -44.40 | -25.97 | -29.63 | -27.80 | -31.75 | -31.16 | -6.76 | -0.53 | -18.36 | 33.34 | -24.34 | -22.64 | -10.25 | -22.26 | -33.74 | -26.66 | -24.77 | -19.66 | -16.89 | -14.41 | -15.76 | -7.15 | -9.09 | -2.56 | -9.99 | -3.17 | -1.07 | 2.36 | -1.14 | |
| Allocated Share Based Compensation Expense | 10.13 | NA | 7.81 | 8.43 | 8.86 | NA | 6.27 | 6.66 | 7.74 | NA | 4.36 | 3.69 | 3.31 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Net Income Loss | -43.94 | -42.21 | -37.31 | -39.84 | -44.26 | -26.41 | -33.50 | -32.55 | -36.26 | -32.54 | -6.67 | -0.43 | -18.16 | 33.65 | -23.77 | -21.55 | -8.26 | -20.26 | -31.03 | -23.96 | -22.08 | -16.99 | -15.96 | -13.62 | -15.09 | -6.86 | -9.09 | -2.68 | -11.44 | -4.58 | -1.11 | 2.32 | -0.89 | |
| Comprehensive Income Net Of Tax | -43.76 | -40.66 | -36.05 | -40.19 | -42.28 | -25.65 | -35.65 | -33.98 | -38.27 | -32.76 | -6.69 | -0.49 | -18.27 | 33.38 | -24.26 | -21.94 | -7.46 | -20.41 | -31.13 | -23.59 | -21.65 | -16.68 | -15.82 | -13.49 | -15.89 | -7.24 | -9.07 | -2.73 | -11.45 | -4.26 | -1.11 | 0.18 | -0.89 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | 405.83 | 452.39 | 487.33 | 517.10 | 551.79 | 610.38 | 618.50 | 603.85 | 625.17 | 643.07 | 424.33 | 426.57 | 396.42 | 416.55 | 384.75 | 401.75 | 424.23 | 435.20 | 451.50 | 480.15 | 494.23 | 509.00 | 523.12 | 306.02 | 314.84 | 329.36 | 121.94 | 130.41 | 131.11 | 62.18 | NA | NA | NA | |
| Liabilities And Stockholders Equity | 405.83 | 452.39 | 487.33 | 517.10 | 551.79 | 610.38 | 618.50 | 603.85 | 625.17 | 643.07 | 424.33 | 426.57 | 396.42 | 416.55 | 384.75 | 401.75 | 424.23 | 435.20 | 451.50 | 480.15 | 494.23 | 509.00 | 523.12 | 306.02 | 314.84 | 329.36 | 121.94 | 130.41 | 131.11 | 62.18 | NA | NA | NA | |
| Stockholders Equity | 47.78 | 88.10 | 120.38 | 148.45 | 191.09 | 262.10 | 277.62 | 304.31 | 330.75 | 356.43 | 383.61 | 385.73 | 381.94 | 396.73 | 360.24 | 381.44 | 400.56 | 405.01 | 420.89 | 448.42 | 468.15 | 486.37 | 499.68 | 284.98 | 294.53 | 307.58 | 101.36 | 109.17 | 110.11 | -38.25 | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets Current | 372.42 | 406.83 | 428.00 | 438.54 | 437.15 | 447.20 | 450.44 | 452.81 | 512.41 | 553.88 | 386.64 | 398.06 | 387.13 | 396.56 | 345.81 | 384.52 | 371.06 | 377.73 | 424.60 | 430.99 | 421.94 | 434.22 | 503.02 | 271.82 | 251.94 | 252.70 | 120.33 | 115.85 | 110.16 | 58.21 | NA | NA | NA | |
| Cash And Cash Equivalents At Carrying Value | 53.70 | 35.97 | 26.30 | 35.21 | 94.56 | 71.31 | 58.55 | 71.70 | 166.41 | 495.73 | 336.33 | 332.25 | 284.15 | 250.46 | 209.15 | 221.17 | 165.32 | 171.02 | 182.90 | 146.55 | 105.85 | 113.60 | 293.41 | 57.06 | 69.47 | 81.19 | 26.67 | 30.75 | 96.75 | 51.23 | NA | NA | NA | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 53.70 | 35.97 | 26.30 | 35.21 | 94.56 | 71.31 | 58.55 | 71.70 | 166.41 | 495.73 | 336.39 | 332.31 | 284.21 | 250.52 | 209.21 | 221.23 | 165.38 | 171.08 | 182.96 | 146.61 | 105.91 | 113.66 | 293.47 | 57.12 | 69.53 | 81.25 | 26.73 | 30.81 | 96.81 | 51.29 | 47.19 | 50.65 | NA | |
| Receivables Net Current | 7.09 | 6.85 | 3.27 | 3.18 | 1.52 | 1.42 | 1.18 | 1.03 | 0.92 | 0.88 | 0.76 | 0.64 | 1.25 | NA | NA | NA | 5.00 | 0.00 | NA | 5.00 | NA | 0.00 | 5.00 | NA | NA | 0.00 | 0.00 | 0.00 | 0.00 | 1.23 | NA | NA | NA | |
| Prepaid Expense And Other Assets Current | 10.67 | 9.08 | 11.68 | 5.87 | 4.48 | 4.54 | 6.30 | 9.62 | 5.87 | 4.90 | 11.76 | 6.51 | 5.46 | 2.91 | 7.47 | 6.64 | 3.57 | 3.51 | 3.60 | 3.77 | 6.10 | 6.96 | 4.04 | 3.76 | 2.17 | 2.69 | 3.12 | 3.85 | 1.69 | 1.63 | NA | NA | NA | |
| Available For Sale Securities Debt Securities | 316.44 | 381.96 | 426.95 | 453.52 | 431.52 | 512.87 | 531.93 | 503.93 | 430.40 | 119.47 | 52.98 | 64.08 | 103.27 | 160.74 | 165.37 | 171.03 | 247.38 | 257.51 | 261.52 | 326.42 | 386.52 | 404.31 | 221.34 | 246.07 | 242.57 | 251.00 | 90.05 | 89.52 | 28.68 | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Property Plant And Equipment Gross | 8.31 | 8.32 | 8.32 | 7.93 | 7.72 | 7.67 | 7.38 | 7.31 | 7.25 | 7.21 | 7.18 | 7.72 | 6.82 | 6.73 | 6.66 | 6.43 | 6.41 | 6.30 | 6.25 | 5.91 | 5.89 | 5.64 | 5.44 | 5.16 | 4.69 | 4.64 | 4.44 | 4.43 | 4.41 | 4.27 | NA | NA | NA | |
| Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 6.36 | 6.22 | 6.06 | 5.91 | 5.74 | 5.58 | 5.41 | 5.25 | 5.08 | 4.92 | 4.77 | 5.23 | 5.07 | 4.95 | 5.08 | 4.94 | 4.80 | 4.68 | 4.56 | 4.43 | 4.30 | 4.20 | 4.09 | 4.07 | 4.03 | 3.98 | 3.93 | 3.89 | 3.84 | 3.80 | NA | NA | NA | |
| Property Plant And Equipment Net | 1.95 | 2.10 | 2.25 | 2.02 | 1.98 | 2.09 | 1.97 | 2.06 | 2.16 | 2.28 | 2.41 | 2.49 | 1.75 | 1.78 | 1.58 | 1.50 | 1.61 | 1.62 | 1.70 | 1.48 | 1.58 | 1.45 | 1.34 | 1.09 | 0.66 | 0.67 | 0.51 | 0.54 | 0.57 | 0.47 | NA | NA | NA | |
| Other Assets Noncurrent | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.26 | 0.48 | 0.60 | 1.11 | 1.35 | 1.29 | 1.48 | 1.74 | 1.91 | 2.09 | 0.15 | 0.08 | 0.32 | 0.29 | 0.05 | NA | NA | NA | NA | NA | NA | NA | |
| Available For Sale Debt Securities Amortized Cost Basis | 316.86 | 382.56 | 429.10 | 456.92 | 434.58 | 517.91 | 537.73 | 507.58 | 432.63 | 119.68 | 52.97 | 64.05 | 103.17 | 160.54 | 164.90 | 170.07 | 246.03 | 256.97 | 260.80 | 325.58 | 386.14 | 404.48 | 221.88 | 246.75 | 243.37 | 251.43 | 90.09 | 89.58 | 28.69 | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities Current | 32.30 | 37.44 | 39.18 | 41.63 | 35.80 | 26.05 | 21.06 | 19.87 | 19.78 | 16.10 | 20.89 | 20.62 | 14.47 | 19.82 | 24.47 | 20.13 | 23.25 | 29.54 | 29.73 | 30.62 | 24.75 | 21.84 | 20.87 | 16.79 | 14.34 | 14.09 | 11.17 | 10.08 | 8.13 | 5.71 | NA | NA | NA | |
| Accounts Payable Current | 4.58 | 4.70 | 6.52 | 4.76 | 3.17 | 2.78 | 3.01 | 1.59 | 2.48 | 1.74 | 5.72 | 4.10 | 2.45 | 4.22 | 5.48 | 6.29 | 8.57 | 16.24 | 10.52 | 10.92 | 9.07 | 5.44 | 6.18 | 4.43 | 2.42 | 2.32 | 2.56 | 3.72 | 2.55 | 2.28 | NA | NA | NA | |
| Other Accrued Liabilities Current | NA | 0.24 | 0.69 | 0.17 | 0.20 | 0.30 | 0.14 | 0.13 | 0.13 | 0.15 | 0.13 | 0.49 | 0.19 | 0.23 | 0.22 | 0.21 | 0.23 | 0.27 | 0.31 | 0.34 | 0.46 | 0.76 | 0.77 | 0.31 | 0.53 | 0.33 | 0.17 | 0.21 | 0.11 | 0.08 | NA | NA | NA | |
| Accrued Liabilities Current | 25.90 | 30.97 | 30.92 | 35.16 | 30.96 | 21.63 | 16.45 | 16.71 | 15.76 | 12.85 | 14.07 | 15.96 | 11.83 | 15.26 | 18.14 | 12.92 | 13.78 | 11.05 | 15.29 | 14.10 | 8.40 | 8.76 | 7.14 | 4.84 | 4.41 | 4.88 | 3.60 | 3.23 | 4.33 | 3.43 | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Lease Liability Noncurrent | 15.57 | 16.04 | 16.49 | 16.95 | 17.39 | 17.81 | 18.23 | 18.65 | 19.06 | 19.45 | 19.84 | 20.22 | NA | NA | 0.03 | 0.18 | 0.42 | 0.65 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | 47.78 | 88.10 | 120.38 | 148.45 | 191.09 | 262.10 | 277.62 | 304.31 | 330.75 | 356.43 | 383.61 | 385.73 | 381.94 | 396.73 | 360.24 | 381.44 | 400.56 | 405.01 | 420.89 | 448.42 | 468.15 | 486.37 | 499.68 | 284.98 | 294.53 | 307.58 | 101.36 | 109.17 | 110.11 | -38.25 | NA | NA | NA | |
| Common Stock Value | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | NA | NA | NA | |
| Additional Paid In Capital | 706.41 | 702.97 | 694.59 | 686.61 | 689.07 | 717.80 | 707.66 | 698.70 | 691.16 | 678.58 | 673.00 | 668.43 | 664.15 | 660.66 | 657.56 | 654.49 | 651.68 | 648.67 | 644.15 | 640.55 | 636.69 | 633.25 | 629.89 | 399.37 | 395.42 | 393.02 | 179.55 | 178.30 | 176.51 | 16.67 | NA | NA | NA | |
| Retained Earnings Accumulated Deficit | -658.03 | -614.10 | -571.88 | -534.58 | -494.73 | -450.48 | -424.06 | -390.56 | -358.01 | -321.75 | -289.21 | -282.55 | -282.12 | -263.96 | -297.60 | -273.84 | -252.29 | -244.03 | -223.76 | -192.73 | -168.77 | -146.69 | -129.70 | -113.74 | -100.10 | -85.00 | -78.17 | -69.08 | -66.40 | -54.92 | NA | NA | NA | |
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0.62 | -0.80 | -2.35 | -3.61 | -3.27 | -5.25 | -6.01 | -3.86 | -2.43 | -0.42 | -0.20 | -0.18 | -0.11 | -0.00 | 0.26 | 0.75 | 1.15 | 0.34 | 0.48 | 0.57 | 0.20 | -0.22 | -0.54 | -0.68 | -0.80 | -0.43 | -0.04 | -0.06 | -0.01 | 0.00 | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -37.25 | -34.35 | -36.47 | -25.41 | -24.57 | -10.69 | -17.75 | -24.15 | -21.01 | -25.30 | -7.01 | 9.59 | -23.20 | 37.58 | -17.01 | -19.61 | -15.11 | -15.80 | -22.10 | -15.52 | -16.10 | -12.29 | -14.86 | -8.88 | -12.48 | -4.81 | -3.89 | -2.64 | -8.10 | -5.57 | -3.07 | 1.67 | -2.06 | |
| Net Cash Provided By Used In Investing Activities | 68.62 | 49.18 | 30.64 | -20.45 | 85.40 | 21.50 | -32.43 | -71.00 | -312.91 | -66.69 | 10.84 | 37.96 | 56.73 | 3.60 | 4.73 | 75.39 | 10.75 | 4.04 | 59.86 | 57.88 | 9.66 | -166.15 | 24.61 | -3.06 | 2.15 | -153.06 | -0.49 | -62.42 | -27.09 | -0.00 | 0.00 | -0.01 | -0.04 | |
| Net Cash Provided By Used In Financing Activities | -13.63 | -5.16 | -3.07 | -13.49 | -37.57 | 1.95 | 37.03 | 0.43 | 4.61 | 251.34 | 0.24 | 0.55 | 0.17 | 0.13 | 0.26 | 0.07 | -1.34 | -0.11 | -1.42 | -1.66 | -1.30 | -1.37 | 226.60 | -0.48 | -1.38 | 212.39 | 0.30 | -0.94 | 80.70 | 9.67 | -0.38 | -0.39 | -0.28 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -37.25 | -34.35 | -36.47 | -25.41 | -24.57 | -10.69 | -17.75 | -24.15 | -21.01 | -25.30 | -7.01 | 9.59 | -23.20 | 37.58 | -17.01 | -19.61 | -15.11 | -15.80 | -22.10 | -15.52 | -16.10 | -12.29 | -14.86 | -8.88 | -12.48 | -4.81 | -3.89 | -2.64 | -8.10 | -5.57 | -3.07 | 1.67 | -2.06 | |
| Net Income Loss | -43.94 | -42.21 | -37.31 | -39.84 | -44.26 | -26.41 | -33.50 | -32.55 | -36.26 | -32.54 | -6.67 | -0.43 | -18.16 | 33.65 | -23.77 | -21.55 | -8.26 | -20.26 | -31.03 | -23.96 | -22.08 | -16.99 | -15.96 | -13.62 | -15.09 | -6.86 | -9.09 | -2.68 | -11.44 | -4.58 | -1.11 | 2.32 | -0.89 | |
| Depreciation Depletion And Amortization | 0.16 | 0.17 | 0.16 | 0.16 | 0.17 | 0.18 | 0.17 | 0.16 | 0.16 | 0.17 | 0.17 | 0.16 | 0.12 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.12 | 0.12 | 0.11 | 0.09 | 0.06 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.06 | 0.06 | 0.06 | 0.06 | |
| Share Based Compensation | 10.13 | 8.11 | 7.81 | 8.43 | 8.86 | 6.68 | 6.27 | 6.66 | 7.74 | 3.98 | 4.36 | 3.69 | 3.31 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Investing Activities | 68.62 | 49.18 | 30.64 | -20.45 | 85.40 | 21.50 | -32.43 | -71.00 | -312.91 | -66.69 | 10.84 | 37.96 | 56.73 | 3.60 | 4.73 | 75.39 | 10.75 | 4.04 | 59.86 | 57.88 | 9.66 | -166.15 | 24.61 | -3.06 | 2.15 | -153.06 | -0.49 | -62.42 | -27.09 | -0.00 | 0.00 | -0.01 | -0.04 | |
| Payments To Acquire Property Plant And Equipment | 0.03 | 0.28 | 0.16 | 0.19 | 0.17 | 0.17 | 0.05 | 0.08 | 0.06 | 0.01 | 0.17 | 0.86 | 0.32 | 0.31 | 0.09 | 0.08 | 0.09 | 0.10 | 0.28 | 0.24 | 0.18 | 0.21 | 0.32 | 0.30 | 0.23 | 0.12 | 0.01 | 0.07 | 0.09 | 0.00 | 0.00 | 0.01 | 0.04 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Financing Activities | -13.63 | -5.16 | -3.07 | -13.49 | -37.57 | 1.95 | 37.03 | 0.43 | 4.61 | 251.34 | 0.24 | 0.55 | 0.17 | 0.13 | 0.26 | 0.07 | -1.34 | -0.11 | -1.42 | -1.66 | -1.30 | -1.37 | 226.60 | -0.48 | -1.38 | 212.39 | 0.30 | -0.94 | 80.70 | 9.67 | -0.38 | -0.39 | -0.28 | |
| Payments For Repurchase Of Common Stock | NA | 0.00 | 0.00 | 12.47 | 37.53 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 | |
| Glaxo Smith Kline, Anaptys Bio Generated Anti P D1 Jemperli Dostarlimab, Cumulative Milestones Recognized | 93.00 | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Anaptys Bio Generated Anti T I M3 G S K4069889 A Cobolimab, Cumulative Milestones Recognized | 13.00 | 0.00 | 0.00 | 0.00 | 13.00 | 5.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Jemperli Royalty Monetization Agreement | 6.20 | NA | 2.50 | 2.80 | 0.60 | NA | 0.30 | 0.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Royalty Agreement | 7.20 | NA | NA | NA | 1.40 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Zejula Royalty Monetization Agreement | 1.00 | 1.00 | 0.80 | 0.70 | 0.80 | NA | NA | NA | 0.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Excluding Assessed Tax | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 | |
| Glaxo Smith Kline, Anaptys Bio Generated Anti P D1 Jemperli Dostarlimab, Cumulative Milestones Recognized | 93.00 | NA | 0.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Anaptys Bio Generated Anti T I M3 G S K4069889 A Cobolimab, Cumulative Milestones Recognized | 13.00 | 0.00 | 0.00 | 0.00 | 13.00 | 5.00 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Jemperli Royalty Monetization Agreement | 6.20 | NA | 2.50 | 2.80 | 0.60 | NA | 0.30 | 0.60 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Royalty Agreement | 7.20 | NA | NA | NA | 1.40 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Glaxo Smith Kline, Zejula Royalty Monetization Agreement | 1.00 | 1.00 | 0.80 | 0.70 | 0.80 | NA | NA | NA | 0.70 | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | NA | |
| Revenue From Contract With Customer Including Assessed Tax | 7.18 | 9.01 | 3.32 | 3.46 | 1.37 | 6.81 | 1.29 | 1.22 | 0.97 | 1.01 | 20.89 | 30.03 | 11.25 | 60.00 | 0.00 | 0.00 | 15.00 | 3.00 | 0.00 | 5.00 | 0.00 | 0.00 | 5.00 | 0.00 | 0.00 | 3.00 | 0.00 | 7.00 | 0.00 | 2.75 | 3.21 | 5.85 | 4.87 |
